Mapping the locations of estradiol and potent neuroprotective analogues in phospholipid bilayers by REDOR

Drug Development Research

Volumn 66, Issue 2, 2005, Pages 93-102

  Cegelski, Lynette ^a   Rice, Charles V ^a,c   O'Connor, Robert D ^a,d   Caruano, Amy L ^b   Tochtrop, Gregory P ^b,e   Cai, Zu Yun ^b   Covey, Douglas F ^b   Schaefer, Jacob ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

Estrogens; Lipid bilayers; Membranes; Neuroprotection; REDOR; Solid state NMR

Indexed keywords

17BETA 2 (1 ADAMANTYL)ESTRADIOL; 17BETA ESTRADIOL 17 BENZOATE; ADAMANTANE DERIVATIVE; DIPALMITOYLPHOSPHATIDYLCHOLINE; ESTRADIOL; ESTRADIOL BENZOATE; FREE RADICAL; NANDROLONE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN REGION; CELL DAMAGE; CORRELATION ANALYSIS; ESTROGEN ACTIVITY; EXPERIMENTAL MODEL; NEUROPATHOLOGY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PARKINSON DISEASE; PHOSPHOLIPID BILAYER; PROTEIN LOCALIZATION; ROTATIONAL ECHO DOUBLE RESONANCE; STROKE; STRUCTURE ACTIVITY RELATION;

EID: 33644846396     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20048     Document Type: Article

References (47)

1. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizz NW, Dyda F, Reed J, Tycko R. 2000. Amyloid fibril formation by Aβ16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39: 13748-13759.
2. Barclay LRC. 1993. Model biomembranes: quantitative studies of peroxidation, antioxidant action, partitioning, and oxidative stress. Can J Chem 71:1-16.
3. Behl C, Manthey D. 2000. Neuroprotective activities of estrogen: an update. J Neurocytol 29:351-359.
4. Cegelski L, Kim SJ, Hing AW, Studelska DR, O'Connor RD, Mehta AK, Schaefer J. 2002. Rotational-echo double resonance characterization of the effects of vancomycin on cell wall synthesis in Staphylococcus aureus. Biochemistry 41:13053-13058.
5. 15N labeling. J Biol Chem 280:39238-39245.
6. Dykens JA, Caroll AK, Wiley S, Covey DF, Cai ZY, Zhao L, Wen R, 2004. Photoreceptor preservation in the S334ter model of retinitis pigmentosa by a novel estradiol analog. Biochem Pharmacol 68: 1971-1984.
7. Garcia-Segura LM, Azcoitia I, DonCarlos LL. 2001. Neuroprotection by estradiol. Prog Neurobiol 63:29-60.
8. Gordon KB, Macrae IM, Carswell HVO. 2005. Effects of 17β-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res 1036:155-162.
9. Green PS, Gordon K, Simpkins JW. 1997. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235.
10. Green PS, Yang SH, Nilsson KR, Kumar AS, Covey DF, Simpkins JW. 2001. The nonfeminizing enantiomer of 17β-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology 142:400-406.
11. Gullion T, Schaefer J. 1989a. Detection of weak heteronuclear dipolar couplings by rotational-echo double-resonance nuclear magnetic resonance. In: Advances in magnetic resonance. New York: Academic Press, p 57-83.
12. Gullion T, Schaefer J. 1989b. Rotational-echo double-resonance NMR. J Magn Reson 81:196-200.
13. Gullion T, Baker DB, Conradi MS. 1990. New, compensated Carr-Purcell sequences. J Magn Reson 89:479-484.
14. Hirsh D, Hammer J, Maloy JW, Blazyk J, Schaefer J. 1996. Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry 35:12733-12741.
15. Kagan VE, Serbinova EA, Bakalova RA, Stoytchev TS, Erin AN, Prilipko LL, Evstigneeva RP. 1990. Mechanisms of stabilization of biomembranes by α-tocopherol: the role of the hydrocarbon chain in the inhibition of lipid-peroxidation. Biochem Pharmacol 40:2403-2413.
16. Kim SJ, Cegelski L, Studelska DR, O'Connor RD, Mehta AK, Schaefer J. 2002. Rotational-echo double resonance characterization of vancomycin binding sites in Staphylococcus aureus. Biochemistry 41:6967-6977.
17. Kumar DM, Perez E, Cai ZY, Aoun P, Brun-Zinkernagel AM, Covey DF, Simpkins JW, Agarwal N. 2005. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Rad Biol Med 38: 1152-1163.
18. Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruizlarrea MB. 1995. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in-vitro. Lipids 30:141-146.
19. Liu R, Yang SH, Perez E, Yi KD, Wu SS, Eberst K, Prokai L, Prokai-Tatrai K, Cai ZY, Covey DF, Day AL, Simpkins JW. 2002. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 33:2485-2491.
20. Lunn WH, Farkas E. 1968. The adamantyl carbonium ion as a dehydrogenating agent, its reactions with estrone. Tetrahedron 24:6773-6776.
21. McDowell LM, Schaefer J. 1996. High-resolution NMR of biological solids. Curr Opin Struct Biol 6:624-629.
22. McDowell LM, McCarrick MA, Studelska DR, O'Connor RD, Light DR, Guilford WJ, Arnaiz D, Dallas JL, Poliks B, Schaefer J. 2003. Human Factor Xa bound amidine inhibitor conformation by double rotational-echo double-resonance nuclear magnetic resonance and molecular dynamics simulations. J Med Chem 46: 359-363.
23. McDowell LM, Poliks B, Studelska DR, O'Connor RD, Beusen DD, Schaefer J. 2004. Rotational-echo double-resonance NMR-restrained model of the ternary complex of 5-enolpyruvylshikimate-3-phosphate synthase. J Biomol NMR 28:11-29.
24. Miller CP, Jirkovsky I, Hayhurst DA, Adelman SJ. 1996. In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61:305-308.
25. Mooradian AD. 1993. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 45:509-511.
26. Nakamizo T, Urushitani M, Inoue R, Shinohara A, Sawada H, Honda K, Kihara T, Akaike A, Shimohama S. 2000. Protection of cultured spinal motor neurons by estradiol. Neuroreport 11:3493-3497.
27. O'Connor RD, Schaefer J. 2002. Relative CSA-dipolar orientation from REDOR sidebands. J Magn Reson 154:46-52.
28. Pauli J, van Rossum B, Forster H, de Groot HJM, Oschkinat H. 2000. Sample optimization and identification of signal patterns of amino acid side chains in 2D RFDR spectra of the α-spectrin SH3 domain. J Magn Reson 143:411-416.
29. Perez E, Liu R, Yang SH, Cai ZY, Covey DF, Simpkins JW. 2005. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res 1038:216-222.
30. Perez E, Cai ZY, Covey DF, Simpkins JW. 2006. Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization. Drug Dev Res 66:78-92 (this issue).
31. L expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72:1552-1563.
32. 4-3-oxosteroids. Steroids. 59: 621-627.
33. 8.9-dehydro derivatives of 17α-estradiol and 17β-estradiol. Steroids 62:304-310.
34. 9(11)-dehydro-17 β-estradiol. Steroids 62: 688-694.
35. Schaefer J, McKay RA. 1999. Multi-tuned single-coil transmission line probe for nuclear magnetic resonance spectrometer, U.S. Patent 5,861,748.
36. Simpkins JW, Yang S-H, Liu R, Perez E, Cai ZY, Covey DF, Green PS. 2004. Estrogen-like compounds for ischemic neuroprotection. Stroke 35:2648-2651.
37. Simpkins JW, Yang S-H, Wen Y, Singh M. 2005. Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol Life Sci 62:271-280.
38. Smith SO, Kawakami T, Liu W, Ziliox M, Aimoto S. 2001. Helical structure of phospholamban in membrane bilayers. J Mol Biol 313:1139-1148.
39. Straus SK, Bremi T, Ernst RR. 1997. Side-chain conformation and dynamics in a solid peptide. J Biomol NMR 10:119-128.
40. Toke O, Maloy WL, Kim SJ, Blazyk J, Schaefer J. 2004a. Secondary structure and lipid contact of a peptide antibiotic in phospholipid bilayers by REDOR. Biophys J 87:662-674.
41. 3 aggregates in phospholipid bilayers by solid-state NMR. Biophys J 87:675-687.
42. 15N REDOR NMR. Biochemistry 36: 9859-9866.
43. Tristram-Nagle S, Nagle JF. 2004. Lipid bilayers: thermodynamics, structure, fluctuations, and interactions. Chem Phys Lipids 127:3-14.
44. Weldeghiorghis TK, Schaefer J. 2003. Compensating for pulse imperfections in REDOR. J Magn Reson 165:230-236.
45. Wise PM, Dubal DB, Wilson ME, Rau SW. 2000. Estradiol is a neuroprotective factor in in vivo and in vitro models of brain injury. J Neurocytol 29:401-410.
46. Xia S, Cai ZY, Thio LL, Kim-Han JS, Dugan LL, Covey DF, Rothman SM. 2002. The estrogen receptor is not essential for all estrogen neuroprotection: new evidence from a new analog. Neurobiol Dis 9:282-293.
47. 2 steroids. Steroids 39:279-289.